Buprenorphine / Naloxone Sublingual Tablets

Buprenorphine / Naloxone Sublingual Tablets
Product Description

Buprenorphine/Naloxone Sublingual Tablets are indicated for the treatment of opioid dependence as part of a comprehensive medical, social, and psychological support program. The combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, is designed to reduce withdrawal symptoms and cravings while discouraging misuse. Administered sublingually, the tablets provide effective and controlled absorption, supporting stabilization and maintenance therapy in patients with opioid addiction. Available in two strengths (2 mg / 0.5 mg and 8 mg / 2 mg), the product allows flexible dosing tailored to patient needs. It is suitable for adult patients and adolescents over 15 years of age under medical supervision.

Read more Show less

Ethypharm

  • Country/Region:
    France
  • Founded:
    1977
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
  • Active substances: Buprenorphine (as hydrochloride) and naloxone (as hydrochloride dihydrate)
  • Pharmaceutical form: Sublingual tablets
  • Strengths: 2 mg / 0.5 mg and 8 mg / 2 mg
  • Route of administration: Sublingual (placed under the tongue until dissolved)
  • Indication:
    • Substitution treatment for opioid dependence
    • Used in combination with medical, psychological, and social support
  • Pack sizes: 7 tablets and 28 tablets
  • Shelf life: 2 years
  • Storage: Do not store above 30°C
  • Selling Points
    International Approvals/Standards; Packaging; Quality Service;
  • Effective treatment for opioid dependence
  • Dual mechanism combining buprenorphine and naloxone
  • Reduces cravings and withdrawal symptoms
  • Designed to deter misuse and abuse
  • Flexible dosing options with two strengths
  • Suitable for long-term maintenance therapy
  • Part of a comprehensive addiction treatment approach
  • Model
    2 mg / 0.5 mg and 8 mg / 2 mg
  • Supplied from
    France
  • Measured In
    milligram
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Ethypharm

    • Country/Region:
      France
    • Founded:
      1977
    • On CPHI since:
      2015
    • Certificates:
      4
    • Employees:
      1000 - 4999
    Company types
    Contract Service
    Distributor/Import Export
    Manufacturer/Innovator
    Pharmaceutical company
    Primary activities
    Contract Manufacturer
    Custom Manufacturing/Custom Synthesis
    Pharmaceutical Company (innovator finished products)
    View company profile

    More Products from Ethypharm (62)

    • Ampoules

      Product Ampoules

      Ethypharm has 2 sites for sterile ampoules manufacturing
    • Aprepitant

      Product Aprepitant

      Prevention of nausea and vomiting associatedwith highly and moderately emetogenic cancerchemotherapy
    • Argatroban Solution for Infusion

      Product Argatroban Solution for Infusion

      Argatroban is a direct thrombin inhibitor used for anticoagulation in patients with heparin-induced thrombocytopenia type II (HIT II). It is administered by continuous IV infusion and offers rapid, predictable anticoagulant effects. Available as a ready-to-use solution or a concentrate for dilution, it pro...
    • Atosiban Acetate

      Product Atosiban Acetate

      Delay imminent preterm birth
    • Atropine Sulfate

      Product Atropine Sulfate

      To reduce salivary and bronchial secretion.To treat bradycardia induced by drugs or toxicsubstances and acute myocardial infarction
    • Azithromycin 500 mg

      Product Azithromycin 500 mg

      Treatment of the infections, caused by micro-organismssensitive to azithromycin
    • Buprenorphine Hydrochloride

      Product Buprenorphine Hydrochloride

      Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptom...
    • Buprenorphine Hydrochloride Sublingual tablet

      Product Buprenorphine Hydrochloride Sublingual tablet

      Substitution treatment for opioid drug dependence,within a framework of medical, social andpsychological treatment
    • Caffeine Citrate 10 mg/ml

      Product Caffeine Citrate 10 mg/ml

      Treatment of apnoea of prematurity
    • Calcium Folinate Hydrate

      Product Calcium Folinate Hydrate

      Calcium folinate rescue to reduce methotrexate/folic acid antagonist toxicity and manage overdose.In combination with 5-fluorouracil in cytotoxictherapy
    • Captopril

      Product Captopril

      Hypertension, Heart Failure, Myocardial Infarction,Type I Diabetic Nephropathy.Can be used alone and in combination with otherantihypertensive agents, especially thiazide diuretics
    • Cardioplegia Infusion 20 ml

      Product Cardioplegia Infusion 20 ml

      Used during heart surgery to induce cardioplegia
    show all 62 other products

    Ethypharm resources (1)